Introduction Every year more than 5,000 patients undergo a major lower limb amputation in the UK.1-3 Major lower limb amputation is a pivotal life-changing event which can result in significant physical and psychological impacts, depending on the person’s functional ability pre-amputation, the cause of their amputation, their co-morbidities and the level of amputation.4,5 Below knee […]
Read MoreIntroduction The most recent iteration of the Inter-Society Consensus Document for the Management of Peripheral Arterial Disease from 2015 (Trans-Atlantic Inter-Society Consensus; TASC II) has suggested that all types of aorto-iliac occlusive disease (AIOD) may be treated using either an endovascular or open approach, provided the clinical team has sufficient expertise in the given modality, […]
Read MoreIntroduction Diabetic foot ulcers (DFUs) are a common complication of diabetes, preceding over 80% of lower limb amputations in the UK.1 It is estimated that by 2025 more than 5 million people will have diabetes in the UK, with DFUs estimated to affect 25% of this population.1,2 There are several validated DFU classification systems that […]
Read MoreIntroduction Over 4,000 major lower limb amputations (MLLA) are performed per annum in the UK1 for end-stage lower limb arterial disease or profound foot sepsis. Amputation is a significant life event for patients and their carers/families. Although supported by recommendations for optimal practice,2 MLLA can be associated with high mortality and complication rates.3,4 The process […]
Read More